• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗具有种族和基因多样性的成年人群中代谢功能障碍相关脂肪性肝病的患病率及特征:PolyIran-肝脏研究结果

Prevalence and Characteristics of Metabolic Dysfunction-Associated Fatty Liver Disease among an Iranian Adult Population with Ethnic and Genetic Diversity: Results of the PolyIran-Liver Study.

作者信息

Jafari Elham, Merat Shahin, Anoushiravani Amir, Radmard Amir Reza, Roshandel Gholamreza, Sharafkhah Maryam, Khoshnia Masoud, Nateghi Alireza, Shiravi Khuzani Abolfazl, Poustchi Hossein, Malekzadeh Reza

机构信息

Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Middle East J Dig Dis. 2024 Apr;16(2):86-95. doi: 10.34172/mejdd.2024.374. Epub 2024 Apr 30.

DOI:10.34172/mejdd.2024.374
PMID:39131113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11316194/
Abstract

BACKGROUND

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a rising global public health concern. It has been demonstrated that its prevalence and characteristics vary by region and racial/ethnicity. We aimed to investigate the prevalence of MAFLD and its characteristics among Turkmen and non-Turkmen ethnic groups in a multiethnic population region of Iran.

METHODS

In this cross-sectional study, we analyzed baseline data for 1614 participants, aged above 50 years, from the PolyIran-Liver trial who were randomly selected from Gonabad city and determined the prevalence of MAFLD and its demographic and metabolic disorders for both the Turkmen and non-Turkmen ethnic groups. Multivariate binary logistic regressions were applied to identify MAFLD-associated factors for men and women separately for the Turkmen and non-Turkmen populations.

RESULTS

The mean (SD) age of the participants was 59.1(6.7) years. Of the participants, 51.5% (n=831) were men, and 52.9% (n=854) were Turkmen. The prevalence of MAFLD among the overall study population was 39.8% (n=614). It was more common among women (45.8% vs. 34.1% in men, <0.001), non-Turkmens (43.9% vs. 36.1% in Turkmens, <0.001), and at age 50-64 (41.5% vs.36.1% in age≥65 =0.004). The fully adjusted multivariate analysis in sex strata exhibited an independent negative association between Turkmen ethnicity only among men but not among women. The increased waist circumference (WC) was the most common metabolic disorder, observed in more than 95.5% of patients with MAFLD (<0.001). Multivariate analysis in sex/ethnic strata with adjustment for potential confounders revealed an independent association of MAFLD with increased WC, insulin resistance, impaired fasting glucose/diabetes type 2, and high alanine aminotransferase (ALT) among women in both ethnic groups while with elevated triglyceride (TG) only among Turkmen and high body mass index (BMI) only among non-Turkmen women. Increased WC had the strongest independent association with MAFLD among women and the highest odds ratio (OR) with MAFLD in Turkmen women (OR: 6.10; 95% CI 1.56-23.86 vs. 4.80 in non-Turkmen women). Among men, MAFLD was independently associated with insulin resistance, high BMI, and high ALT in both ethnic groups and elevated TG only in non-Turkmen men (all <0.001). Insulin resistance had the strongest independent OR with MAFLD among men with similar size in both ethnic groups (4.68 [95% CI 2.56-8.55]) in non-Turkmen men and 4.37 (95% CI 2.27-8.42 in Turkmen men).

CONCLUSION

This study revealed the high prevalence of MAFLD with a sex and ethnic disparity in the middle-aged population of Gonabad city. Further research is needed to understand the factors contributing to the higher prevalence of MAFLD in this region, particularly in women. Furthermore, considering the diverse ethnic population of Iran, it is suggested that future investigations on the sex and ethnic aspects of MAFLD in the Iranian population be conducted to provide targeted prevention strategies better suited for the Iranian population.

摘要

背景

代谢功能障碍相关脂肪性肝病(MAFLD)是一个日益引起全球公共卫生关注的问题。已经证明,其患病率和特征因地区以及种族/民族而异。我们旨在调查伊朗一个多民族人口地区土库曼族和非土库曼族人群中MAFLD的患病率及其特征。

方法

在这项横断面研究中,我们分析了来自伊朗肝脏多中心试验(PolyIran-Liver trial)的1614名年龄在50岁以上参与者的基线数据,这些参与者是从戈纳巴德市随机选取的,我们确定了土库曼族和非土库曼族人群中MAFLD的患病率及其人口统计学和代谢紊乱情况。应用多变量二元逻辑回归分别确定土库曼族和非土库曼族男性和女性中与MAFLD相关的因素。

结果

参与者的平均(标准差)年龄为59.1(6.7)岁。参与者中,51.5%(n = 831)为男性,52.9%(n = 854)为土库曼族。整个研究人群中MAFLD的患病率为39.8%(n = 614)。在女性中更常见(女性为45.8%,男性为34.1%,P<0.001),在非土库曼族中更常见(非土库曼族为43.9%,土库曼族为36.1%,P<0.001),在50 - 64岁年龄段更常见(50 - 64岁为41.5%,≥65岁为36.1%,P = 0.004)。按性别分层的完全调整多变量分析显示,仅在男性中土库曼族与MAFLD之间存在独立的负相关,而在女性中不存在。腰围(WC)增加是最常见的代谢紊乱,在超过95.5%的MAFLD患者中观察到(P<0.001)。在按性别/种族分层并对潜在混杂因素进行调整的多变量分析中,在两个民族的女性中,MAFLD与WC增加、胰岛素抵抗、空腹血糖受损/2型糖尿病以及高丙氨酸氨基转移酶(ALT)独立相关,而在土库曼族中仅与甘油三酯(TG)升高相关,在非土库曼族女性中仅与高体重指数(BMI)相关。WC增加在女性中与MAFLD的独立关联最强,在土库曼族女性中与MAFLD的比值比(OR)最高(OR:6.10;95%CI 1.56 - 23.86,非土库曼族女性为4.80)。在男性中,两个民族的MAFLD均与胰岛素抵抗、高BMI和高ALT独立相关,仅在非土库曼族男性中与TG升高相关(均P<0.001)。在两个民族中体型相似的男性中,胰岛素抵抗与MAFLD的独立OR最强(非土库曼族男性为4.68 [95%CI 2.56 - 8.55]),土库曼族男性为4.37(95%CI 2.27 - 8.42)。

结论

本研究揭示了戈纳巴德市中年人群中MAFLD的高患病率以及性别和种族差异。需要进一步研究以了解该地区MAFLD患病率较高的因素,特别是在女性中。此外,考虑到伊朗的多民族人口,建议未来对伊朗人群中MAFLD的性别和种族方面进行调查,以提供更适合伊朗人群的针对性预防策略。

相似文献

1
Prevalence and Characteristics of Metabolic Dysfunction-Associated Fatty Liver Disease among an Iranian Adult Population with Ethnic and Genetic Diversity: Results of the PolyIran-Liver Study.伊朗具有种族和基因多样性的成年人群中代谢功能障碍相关脂肪性肝病的患病率及特征:PolyIran-肝脏研究结果
Middle East J Dig Dis. 2024 Apr;16(2):86-95. doi: 10.34172/mejdd.2024.374. Epub 2024 Apr 30.
2
Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population.使用日本人群中与胰岛素抵抗相关的指标预测和验证代谢功能障碍相关的脂肪性肝病。
Metab Syndr Relat Disord. 2023 Nov;21(9):489-496. doi: 10.1089/met.2023.0116. Epub 2023 Oct 25.
3
Predictors of metabolic-associated fatty liver disease (MAFLD) in adults: a population-based study in Northeastern Iran.成人代谢相关脂肪性肝病(MAFLD)的预测因素:伊朗东北部的一项基于人群的研究。
Gastroenterol Hepatol Bed Bench. 2021 Fall;14(Suppl1):S102-S111.
4
Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study.中国城市人群代谢相关脂肪性肝病的流行情况及其危险因素:一项横断面对比研究。
BMC Gastroenterol. 2021 May 10;21(1):212. doi: 10.1186/s12876-021-01782-w.
5
The association of triglyceride-glucose-waist circumference with metabolic associated fatty liver disease and the severity of liver steatosis and fibrosis in American adults: a population-based study.甘油三酯-葡萄糖-腰围与代谢相关脂肪性肝病及其严重程度的相关性:一项基于人群的美国成年人研究。
Scand J Gastroenterol. 2024 May;59(5):561-569. doi: 10.1080/00365521.2024.2305268. Epub 2024 Jan 18.
6
Lack of awareness and ethnic polarity is a major cause of metabolic associated fatty liver disease in high-risk diabetes population in South London.缺乏认知和种族两极分化是伦敦南部高危糖尿病患者代谢相关脂肪性肝病的主要原因。
Ther Adv Chronic Dis. 2024 Jul 30;15:20406223241264539. doi: 10.1177/20406223241264539. eCollection 2024.
7
Genetic and Lifestyle Risk Factors of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Relationship with Premature Coronary Artery Disease: A Study on the Pars Cohort.遗传和生活方式因素与代谢相关脂肪性肝病及其与早发冠心病的关系:帕斯卡队列研究。
Arch Iran Med. 2024 May 1;27(5):248-254. doi: 10.34172/aim.2024.36.
8
Prevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China.中国新乡地区代谢相关脂肪性肝病的流行状况及其危险因素分析。
Int J Environ Res Public Health. 2020 Mar 11;17(6):1818. doi: 10.3390/ijerph17061818.
9
Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population.腰围身高比是西方中国男性人群代谢相关脂肪性肝病的最佳人体测量指标。
Lipids Health Dis. 2021 Oct 27;20(1):145. doi: 10.1186/s12944-021-01568-9.
10
Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factors.将非酒精性脂肪性肝病重新命名为代谢相关脂肪性肝病对其患病率、特征及危险因素的影响。
World J Hepatol. 2023 Aug 27;15(8):985-1000. doi: 10.4254/wjh.v15.i8.985.

本文引用的文献

1
Prevalence of non-alcoholic fatty liver and its related factors in Iran: Systematic review and meta-analysis.伊朗非酒精性脂肪肝的患病率及其相关因素:系统评价与荟萃分析
J Educ Health Promot. 2023 Oct 31;12:356. doi: 10.4103/jehp.jehp_1056_22. eCollection 2023.
2
Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study.按种族和民族划分的非酒精性脂肪肝的肝脏和死亡率结局的差异:一项纵向真实世界研究。
Clin Mol Hepatol. 2023 Oct;29(4):1002-1012. doi: 10.3350/cmh.2023.0205. Epub 2023 Sep 11.
3
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)的全球流行病学:系统评价。
Hepatology. 2023 Apr 1;77(4):1335-1347. doi: 10.1097/HEP.0000000000000004. Epub 2023 Jan 3.
4
Comparing the Diagnostic Criteria of MAFLD and NAFLD in the Chinese Population: A Population-based Prospective Cohort Study.比较中国人群中MAFLD与NAFLD的诊断标准:一项基于人群的前瞻性队列研究。
J Clin Transl Hepatol. 2022 Feb 28;10(1):6-16. doi: 10.14218/JCTH.2021.00089. Epub 2021 Jul 1.
5
Prevalence and risk factors of metabolic-associated fatty liver disease during 2014-2018 from three cities of Liaoning Province: an epidemiological survey.2014-2018 年辽宁省三个城市代谢相关脂肪性肝病的患病率及相关危险因素:一项流行病学调查。
BMJ Open. 2022 Feb 17;12(2):e047588. doi: 10.1136/bmjopen-2020-047588.
6
Predictors of metabolic-associated fatty liver disease (MAFLD) in adults: a population-based study in Northeastern Iran.成人代谢相关脂肪性肝病(MAFLD)的预测因素:伊朗东北部的一项基于人群的研究。
Gastroenterol Hepatol Bed Bench. 2021 Fall;14(Suppl1):S102-S111.
7
Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease.代谢(功能障碍)相关脂肪性肝病的流行病学与临床结局
J Clin Transl Hepatol. 2021 Dec 28;9(6):972-982. doi: 10.14218/JCTH.2021.00201. Epub 2021 Aug 30.
8
Sex-Specific Differences in the Association Between Race/Ethnicity and NAFLD Among US Population.美国人群中种族/族裔与非酒精性脂肪性肝病(NAFLD)关联的性别差异
Front Med (Lausanne). 2021 Dec 2;8:795421. doi: 10.3389/fmed.2021.795421. eCollection 2021.
9
Association of genetic variations with NAFLD in lean individuals.瘦人非酒精性脂肪性肝病相关的遗传变异。
Liver Int. 2022 Jan;42(1):149-160. doi: 10.1111/liv.15078. Epub 2021 Oct 12.
10
Role of Insulin Resistance in MAFLD.胰岛素抵抗在 MAFLD 中的作用。
Int J Mol Sci. 2021 Apr 16;22(8):4156. doi: 10.3390/ijms22084156.